Tiwaskar, M., Langote, A., Kashyap, R
Today, we announced new six-month data from our second Phase 3 trial in treatment-resistant depression (TRD)
Laboratory Monitoring Depending on your medical history and treatment goals, your provider may recommend periodic laboratory testing and clinical evaluation throughout therapy
This means some users may respond well, while others may not see the same benefits
Paracetamol (maximum 4 g daily) is a safe first-line option for most patients, whilst ibuprofen (maximum 1.2 g daily for over-the-counter use) may be used if paracetamol proves insufficient, provided you have no contraindications such as kidney disease or gastric ulcer history
Furthermore, because it is not FDA-approved for human use, the supply chain is the Wild West